FDAFDA · Food and drugs·Recall number D-1246-2014
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
Published April 30, 2014 · Recall initiated: February 20, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- NICORETTE
- Manufacturer
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
- Distributor
- U.S. Nationwide
- Lot
- (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.